Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
פורמט: Article
שפה:English
יצא לאור: Wiley 2019-01-01
סדרה:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
נושאים:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
גישה מקוונת:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

אינטרנט

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

פריטים דומים